Marion M. Den Boer-Stevense
Breda, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 26, 2025
Long-Term Survival in Patients With Advanced Melanoma.
Journal: JAMA network open
Published: August 14, 2024
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
Journal: The New England journal of medicine
Published: June 03, 2024
Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study.
Journal: International journal of cancer
Published: December 01, 2023
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.
Journal: EClinicalMedicine
Published: September 11, 2023
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
Journal: Cancer
Published: August 24, 2023
A prediction model for response to immune checkpoint inhibition in advanced melanoma.
Journal: International journal of cancer
Published: July 05, 2023
Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 12, 2023
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
Journal: International journal of cancer
Published: January 02, 2023
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
Journal: The New England journal of medicine
Published: December 08, 2022
Last Updated: 09/26/2026